# Rani Therapeutics funding: rounds and investors > Rani Therapeutics has raised $168M across 5 rounds since 2013. Investors include Google Ventures, Novartis and RA Capital Management. Source: https://millionrounds.com/company/rani-therapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Rani Therapeutics* 5 rounds we have observed, with the 20 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$168M** raised across 5 rounds since 2013, from 5 sources **$15M** Series C **$39M** Series D **$53M** Round **$60M** Round - **Latest round:** Round, $60M Oct 2025 - **Investors:** 20 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2013 2015 2017 2019 2021 2023 2025 **?** Series B **$15M** Series C **$39M** Series D **$53M** Round **$60M** Round - **First round:** Series B - **Biggest round:** $60M - **Usual gap between rounds:** 2.3 years ## The rounds - **Oct 2025** Round **$60M** *3 new* *1 returning* [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Invus](https://millionrounds.com/fund/invus) [Novartis](https://millionrounds.com/fund/novartis) [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) Source recorded SEC filing: $60M sold, first sale Oct 2025 - **Feb 2018** Round **$53M** *7 new* *2 returning* [Google Ventures](https://millionrounds.com/fund/gv) [Novartis](https://millionrounds.com/fund/novartis) [Cathay Capital](https://millionrounds.com/fund/cathay-capital) [AstraZeneca](https://millionrounds.com/fund/astrazeneca) [Ping An Capital](https://millionrounds.com/fund/ping-an-capital) [Shire](https://millionrounds.com/fund/shire) [Virtus Ventures](https://millionrounds.com/fund/virtus-ventures) Bossa GeneScience Reported by FinSMEs - **Sept 2017** Series D **$39M** *1 returning* [Google Ventures](https://millionrounds.com/fund/gv) Reported by FinSMEs SEC filing: $39M sold, first sale Aug 2017 - **May 2015** Series C **$15M** *8 new* *1 returning* [Google Ventures](https://millionrounds.com/fund/gv) [Novartis](https://millionrounds.com/fund/novartis) [Incube Ventures](https://millionrounds.com/fund/incube-ventures) [Western Life Sciences Venture Fund](https://millionrounds.com/fund/western-life-sciences-venture-fund) [Pacific Opportunity Capital Ltd.](https://millionrounds.com/fund/pacific-opportunity-capital-ltd) [The Stevanato Group](https://millionrounds.com/fund/the-stevanato-group) [VentureHealth](https://millionrounds.com/fund/venturehealth) Crystal Horizon Investments Pinemount Investment From a historical funding record SEC filing: $15M sold, first sale May 2015 - **Aug 2013** Series B **Amount undisclosed** *2 new* [Google Ventures](https://millionrounds.com/fund/gv) [InCube Ventures](https://millionrounds.com/fund/incube-ventures-llc) Reported by finsmes.com ## Founders and team From Rani Therapeutics's own website and the SEC filings it signed: 11 on the team. - **Talat Imran** Chief Executive Officer - **Anil Patel** Vice President of Quality - **Alireza Javadi** Chief Technical Officer - **Kate McKinley** Chief Business Officer - **Nic Maestas** Chief Financial Officer - **Arvinder Dhalla** VP, Clinical Development - **Kyle Horlen** VP of Nonclinical Development - **Jean-Luc Butel** Director at Takeda, Novo Holdings, and SG Innovate - **Mir Hashim** Executive Officer, Director i - **Mir Imran** Executive Chairman & Director - **Svai Sanford** Executive Officer i On the board, as filed i *Andrew Farquharson* *Dennis Ausiello* *Maulik Nanavaty* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2013 **Series C** 2015 **Series D** 2017 **Round** 2018 **Round** 2025 [Google Ventures](https://millionrounds.com/fund/gv) [Novartis](https://millionrounds.com/fund/novartis) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Invus](https://millionrounds.com/fund/invus) [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) [Cathay Capital](https://millionrounds.com/fund/cathay-capital) [AstraZeneca](https://millionrounds.com/fund/astrazeneca) [Ping An Capital](https://millionrounds.com/fund/ping-an-capital) [Shire](https://millionrounds.com/fund/shire) [InCube Ventures](https://millionrounds.com/fund/incube-ventures-llc) ## Everyone who backed them [Google Ventures](https://millionrounds.com/fund/gv) Corporate VC **4** rounds [Novartis](https://millionrounds.com/fund/novartis) VC firm **3** rounds [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round [Invus](https://millionrounds.com/fund/invus) Private equity **1** round [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) VC firm **1** round [Cathay Capital](https://millionrounds.com/fund/cathay-capital) Private equity **1** round [AstraZeneca](https://millionrounds.com/fund/astrazeneca) Growth equity **1** round [Ping An Capital](https://millionrounds.com/fund/ping-an-capital) Corporate VC **1** round [Shire](https://millionrounds.com/fund/shire) Corporate VC **1** round [InCube Ventures](https://millionrounds.com/fund/incube-ventures-llc) Corporate VC **1** round [Incube Ventures](https://millionrounds.com/fund/incube-ventures) Growth equity **1** round [Western Life Sciences Venture Fund](https://millionrounds.com/fund/western-life-sciences-venture-fund) VC firm **1** round [Pacific Opportunity Capital Ltd.](https://millionrounds.com/fund/pacific-opportunity-capital-ltd) Growth equity **1** round [The Stevanato Group](https://millionrounds.com/fund/the-stevanato-group) VC firm **1** round [VentureHealth](https://millionrounds.com/fund/venturehealth) VC firm **1** round [Virtus Ventures](https://millionrounds.com/fund/virtus-ventures) VC firm **1** round Bossa no record of our own yet **1** round Crystal Horizon Investments no record of our own yet **1** round GeneScience no record of our own yet **1** round Pinemount Investment no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=rani-therapeutics). ## Quick answers about Rani Therapeutics ### Who invested in Rani Therapeutics? Rani Therapeutics's investors include Google Ventures, Novartis, RA Capital Management, Invus and Samsara BioCapital, and 15 more on record. ### How much has Rani Therapeutics raised? Rani Therapeutics has raised $168M across 5 rounds since 2013. One round did not disclose an amount, so the total is a floor. ### When did Rani Therapeutics last raise? Rani Therapeutics's most recent round was an Undisclosed round of $60M in Oct 2025. ### What was Rani Therapeutics's biggest round? Its most recent round, $60M in Oct 2025, is also its largest on record. ### Who backed Rani Therapeutics first? Rani Therapeutics's first round on record, in Aug 2013, was backed by Google Ventures and InCube Ventures. ### What stage is Rani Therapeutics at? Rani Therapeutics's latest named round is an Undisclosed round, in Oct 2025. ### Where is Rani Therapeutics based? Rani Therapeutics is based in the United States. ## Companies like Rani Therapeutics In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app